{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:18:20Z","timestamp":1787066300206,"version":"build-2736575974"},"publisher-location":"Boston, MA","reference-count":108,"publisher":"Springer US","isbn-type":[{"value":"9781461441175","type":"print"},{"value":"9781461441182","type":"electronic"}],"license":[{"start":{"date-parts":[[2012,8,10]],"date-time":"2012-08-10T00:00:00Z","timestamp":1344556800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013]]},"DOI":"10.1007\/978-1-4614-4118-2_10","type":"book-chapter","created":{"date-parts":[[2012,9,18]],"date-time":"2012-09-18T17:26:08Z","timestamp":1347989168000},"page":"155-172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Paroxysmal Nocturnal Hemoglobinuria and the Complement System: Recent Insights and Novel Anticomplement Strategies"],"prefix":"10.1007","author":[{"given":"Antonio M.","family":"Risitano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,10]]},"reference":[{"key":"10_CR2","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1073\/pnas.96.9.5209","volume":"96","author":"DJ Araten","year":"1999","unstructured":"Araten DJ, Nafa K, Pakdeesuwan K et al (1999) Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria genotype and phenotype are present in normal individuals. Proc Natl Acad Sci USA 96:5209\u20135214","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR3","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1038\/sj.leu.2402694","volume":"16","author":"DJ Araten","year":"2002","unstructured":"Araten DJ, Bessler M, McKenzie S et al (2002) Dynamics of hematopoiesis in paroxysmal nocturnal hemoglobinuria (PNH): no evidence for intrinsic growth advantage of PNH clones. Leukemia 16:2243\u20132248","journal-title":"Leukemia"},{"key":"10_CR4","doi-asserted-by":"crossref","first-page":"25347","DOI":"10.1016\/S0021-9258(19)74046-0","volume":"267","author":"C Armstrong","year":"1999","unstructured":"Armstrong C, Schubert J, Ueda E et al (1992) Affected paroxysmal nocturnal hemoglobinuria T lymphocytes harbor a common defect in assembly of N-acetyl-D-glucosamine inositol phospholipid corresponding to that in class A Thy-1-urine lymphoma mutants. J Biol Chem 267:25347\u201325351","journal-title":"J Biol Chem"},{"key":"10_CR5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/s00415-005-0871-3","volume":"252","author":"HJ Audebert","year":"2005","unstructured":"Audebert HJ, Planck J, Eisenburg M et al (2005) Cerebral ischemic infarction in paroxysmal nocturnal hemoglobinuria report of 2 cases and updated review of 7 previously published patients. J Neurol 252:1379\u20131386","journal-title":"J Neurol"},{"key":"10_CR6","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"114","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Young NS, Antonioli E et al (2008) Multicenter phase III study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood 114:1840\u20131847","journal-title":"Blood"},{"key":"10_CR115","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood-2007-06-094136","volume":"114","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA (2009) How I treat paroxysmal nocturnal hemoglobinuria. Blood 113:6522\u20136527","journal-title":"Blood"},{"key":"10_CR7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.leu.2403678","volume":"19","author":"G Chen","year":"2005","unstructured":"Chen G, Zeng W, Maciejewski JP et al (2005) Differential gene expression in hematopoietic progenitors from paroxysmal nocturnal hemoglobinuria patients reveals an apoptosis\/immune response in \u2018normal\u2019 phenotype cells. Leukemia 19:862\u2013868","journal-title":"Leukemia"},{"key":"10_CR8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1182\/blood.V6.3.270.270","volume":"63","author":"WH Crosby","year":"1951","unstructured":"Crosby WH (1951) Paroxysmal nocturnal hemoglobinuria; a classic description by Paul Str\u00fcbling in 1882, and a bibliography of the disease. Blood 63:270\u2013284","journal-title":"Blood"},{"key":"10_CR9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1182\/blood.V30.2.251.251","volume":"30","author":"W Dameshek","year":"1967","unstructured":"Dameshek W (1967) Riddle: what do aplastic anemia, paroxysmal nocturnal hemoglobinuria (PNH) and \u201chypoplastic\u201d leukemia have in common? Blood 30:251\u2013254","journal-title":"Blood"},{"key":"10_CR10","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP Latour de","year":"2008","unstructured":"de Latour RP, Mary JY, Salanoubat C et al (2008) French Association of Young Hematologists Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood 112:3099\u20133106","journal-title":"Blood"},{"key":"10_CR11","first-page":"99","volume-title":"Bone marrow failure syndromes","author":"DE Dunn","year":"2000","unstructured":"Dunn DE, Liu JM, Young NS (2000) Paroxysmal nocturnal hemoglobinuria. In: Young NS (ed) Bone marrow failure syndromes. W.B. Saunders Company, Philadelphia, pp 99\u2013121"},{"key":"10_CR12","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1182\/blood.V87.6.2546.bloodjournal8762546","volume":"87","author":"M Endo","year":"1996","unstructured":"Endo M, Ware RE, Vreeke TM et al (1996) Molecular basis of the heterogeneity of expression of glycosyl phosphatidylinositol anchored proteins in paroxysmal nocturnal hemoglobinuria. Blood 87:2546\u20132557","journal-title":"Blood"},{"issue":"110","key":"10_CR13","first-page":"1290","volume":"15","author":"VP Ferreira","year":"2007","unstructured":"Ferreira VP, Pangburn MK (2007) Factor H mediated cell surface protection from complement is critical for the survival of PNH erythrocytes. Blood 15(110):1290\u20131292","journal-title":"Blood"},{"key":"10_CR14","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1182\/blood-2006-10-052381","volume":"109","author":"L Gargiulo","year":"2007","unstructured":"Gargiulo L, Lastraioli S, Cerruti G et al (2007) Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria. Blood 109:5036\u20135042","journal-title":"Blood"},{"key":"10_CR15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2141.1995.tb05371.x","volume":"91","author":"HR Gralnick","year":"1995","unstructured":"Gralnick HR, Vail M, McKeown LP et al (1995) Activated platelets in paroxysmal nocturnal haemoglobinuria. Br J Haematol 91:697\u2013702","journal-title":"Br J Haematol"},{"key":"10_CR16","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/00001721-200310000-00011","volume":"14","author":"M Gr\u00fcnewald","year":"2003","unstructured":"Gr\u00fcnewald M, Siegemund A, Gr\u00fcnewald A et al (2003) Plasmatic coagulation and fibrinolytic system alterations in PNH: relation to clone size. Blood Coagul Fibrinolysis 14:685\u2013695","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10_CR17","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.1182\/blood-2003-01-0009","volume":"102","author":"C Hall","year":"2003","unstructured":"Hall C, Richards S, Hillmen P (2003) Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood 102:3587\u20133591","journal-title":"Blood"},{"key":"10_CR18","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1172\/JCI101081","volume":"18","author":"TH Ham","year":"1939","unstructured":"Ham TH, Dingle JH (1939) Studies on the destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: certain immunological aspects of the hemolytic mechanism with special reference to serum complement. J Clin Invest 18:657\u2013672","journal-title":"J Clin Invest"},{"key":"10_CR19","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3324\/haematol.2009.016121","volume":"95","author":"D Helley","year":"2010","unstructured":"Helley D, de Latour RP, Porcher R et al (2010) French Society of Hematology. Evaluation of hemostasis and endothelial function in patients with paroxysmal nocturnal hemoglobinuria receiving eculizumab. Haematologica 95:574\u2013581","journal-title":"Haematologica"},{"key":"10_CR20","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.3324\/haematol.10836","volume":"92","author":"A Hill","year":"2007","unstructured":"Hill A, Richards SJ, Rother RP et al (2007) Erythropoietin treatment during complement inhibition with eculizumab in a patient with paroxysmal nocturnal hemoglobinuria. Haematologica 92:e31, ECR14","journal-title":"Haematologica"},{"key":"10_CR21","doi-asserted-by":"crossref","first-page":"567","DOI":"10.3324\/haematol.2009.007229","volume":"95","author":"A Hill","year":"2010","unstructured":"Hill A, Rother RP, Arnold L et al (2010) Eculizumab prevents intravascular hemolysis in patients with paroxysmal nocturnal hemoglobinuria and unmasks low-level extravascular hemolysis occurring through C3 opsonization. Haematologica 95:567\u2013573","journal-title":"Haematologica"},{"key":"10_CR22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M et al (1995) Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 333:1253\u20131258","journal-title":"N Engl J Med"},{"key":"10_CR23","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa031688","volume":"350","author":"P Hillmen","year":"2004","unstructured":"Hillmen P, Hall C, Marsh JC et al (2004) Effect of eculizumab on hemolysis and transfusion requirements in patients with paroxysmal nocturnal hemoglobinuria. N Engl J Med 350:552\u2013559","journal-title":"N Engl J Med"},{"key":"10_CR24","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J et al (2006) The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med 355:1233\u20131243","journal-title":"N Engl J Med"},{"key":"10_CR25","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","volume":"110","author":"P Hillmen","year":"2007","unstructured":"Hillmen P, Muus P, Duhrsen U et al (2007) Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood 110:4123\u20134128","journal-title":"Blood"},{"key":"10_CR26","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.89.13.6025","volume":"89","author":"S Hirose","year":"1992","unstructured":"Hirose S, Ravi L, Prince GM et al (1992) Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells. Proc Natl Acad Sci USA 89:6025\u20136029","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR27","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jhep.2009.06.019","volume":"51","author":"J Hoekstra","year":"2009","unstructured":"Hoekstra J, Leebeek FW, Plessier A et al (2009) Paroxysmal nocturnal hemoglobinuria in Budd-Chiari syndrome: findings from a cohort study. J Hepatol 51:696\u2013706","journal-title":"J Hepatol"},{"key":"10_CR28","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1600-065X.2008.00641.x","volume":"223","author":"VM Holers","year":"2008","unstructured":"Holers VM (2008) The spectrum of complement alternative pathway-mediated diseases. Immunol Rev 223:300\u2013316","journal-title":"Immunol Rev"},{"key":"10_CR29","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1172\/JCI114172","volume":"84","author":"MH Holguin","year":"1989","unstructured":"Holguin MH, Fredrick LR, Bernshaw NJ et al (1989a) Isolation and characterization of a membrane protein from \u00adnormal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84:7\u201317","journal-title":"J Clin Invest"},{"key":"10_CR30","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1172\/JCI114311","volume":"84","author":"MH Holguin","year":"1989","unstructured":"Holguin MH, Wilcox LA, Bernshaw NJ et al (1989b) Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 84:1387\u20131394","journal-title":"J Clin Invest"},{"key":"10_CR31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4049\/jimmunol.148.2.498","volume":"148","author":"MH Holguin","year":"1992","unstructured":"Holguin MH, Martin CB, Bernshaw NJ et al (1992) Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor. J Immunol 148:498\u2013502","journal-title":"J Immunol"},{"key":"10_CR32","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood.V93.10.3451.410k27_3451_3456","volume":"93","author":"B Hugel","year":"1999","unstructured":"Hugel B, Soci\u00e9 G, Vu T et al (1999) Elevated levels of circulating procoagulant microparticles in patients with paroxysmal nocturnal hemoglobinuria and aplastic anemia. Blood 93:3451\u20133456","journal-title":"Blood"},{"key":"10_CR33","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V98.7.2248","volume":"98","author":"M Jasinski","year":"2001","unstructured":"Jasinski M, Keller P, Fujiwara Y et al (2001) GATA1-Cre mediates Piga gene inactivation in the erythroid\/megakaryocytic lineage and leads to circulating red cells with a partial deficiency in glycosyl phosphatidylinositol-linked proteins (paroxysmal nocturnal hemoglobinuria type II cells). Blood 98:2248\u20132255","journal-title":"Blood"},{"key":"10_CR34","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1182\/blood.V96.7.2613","volume":"96","author":"A Karadimitris","year":"2001","unstructured":"Karadimitris A, Manavalan JS, Thaler HT et al (2000) Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria. Blood 96:2613\u20132620","journal-title":"Blood"},{"key":"10_CR35","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1182\/blood.V87.9.3600.bloodjournal8793600","volume":"87","author":"K Kawagoe","year":"1996","unstructured":"Kawagoe K, Kitamura D, Okabe M et al (1996) Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria. Blood 87:3600\u20133606","journal-title":"Blood"},{"key":"10_CR36","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1084\/jem.194.5.581","volume":"194","author":"P Keller","year":"2001","unstructured":"Keller P, Payne JL, Tremml G et al (2001) FES-Cre targets phosphatidylinositol glycan class A (PIGA) inactivation to hematopoietic stem cells in the bone marrow. J Exp Med 194:581\u2013589","journal-title":"J Exp Med"},{"key":"10_CR37","doi-asserted-by":"crossref","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM et al (2011) Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood 117:6786\u20136792","journal-title":"Blood"},{"key":"10_CR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1084\/jem.162.1.75","volume":"162","author":"T Kinoshita","year":"1985","unstructured":"Kinoshita T, Medof ME, Silber R et al (1985) Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 162:75\u201392","journal-title":"J Exp Med"},{"key":"10_CR39","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1182\/blood.V33.4.607.607","volume":"33","author":"TR Kunstling","year":"1969","unstructured":"Kunstling TR, Rosse WF (1969) Erythrocyte acetylcholinesterase deficiency in paroxysmal nocturnal hemoglobinuria (PNH). A comparison of the complement-sensitive and insensitive populations. Blood 33:607\u2013616","journal-title":"Blood"},{"key":"10_CR40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2141.1967.tb08736.x","volume":"13","author":"SM Lewis","year":"1967","unstructured":"Lewis SM, Dacie JV (1967) The aplastic anaemia\u2013paroxysmal nocturnal haemoglobinuria syndrome. Br J Haematol 13:236\u2013251","journal-title":"Br J Haematol"},{"key":"10_CR41","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1182\/blood-2009-09-244285","volume":"115","author":"MA Lindorfer","year":"2010","unstructured":"Lindorfer MA, Pawluczkowycz AW, Peek EM et al (2010) A novel approach to preventing the hemolysis of paroxysmal nocturnal hemoglobinuria: both complement-mediated cytolysis and C3 deposition are blocked by a monoclonal antibody specific for the alternative pathway of complement. Blood 115:2283\u20132291","journal-title":"Blood"},{"key":"10_CR42","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s002770100375","volume":"80","author":"H Louwes","year":"2001","unstructured":"Louwes H, Vellenga E, de Wolf JT (2001) Abnormal platelet adhesion on abdominal vessels in asymptomatic patients with paroxysmal nocturnal hemoglobinuria. Ann Hematol 80:573\u2013576","journal-title":"Ann Hematol"},{"key":"10_CR43","first-page":"319","volume-title":"Blood, principles and practice of hematology","author":"L Luzzatto","year":"2003","unstructured":"Luzzatto L, Notaro R (2003) Paroxysmal nocturnal hemoglobinuria. In: Handin RI, Lux SE, Stossel TP (eds) Blood, principles and practice of hematology, 2nd edn. Lippincott Williams & Wilkins, Philadelphia, pp 319\u2013334","edition":"2"},{"key":"10_CR44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(00)81850-4","volume":"88","author":"L Luzzatto","year":"1997","unstructured":"Luzzatto L, Bessler M, Rotoli B (1997) Somatic mutations in paroxysmal nocturnal hemoglobinuria: a blessing in disguise? Cell 88:1\u20134","journal-title":"Cell"},{"key":"10_CR45","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3324\/haematol.2009.017848","volume":"95","author":"L Luzzatto","year":"2010","unstructured":"Luzzatto L, Risitano AM, Notaro R (2010) Paroxysmal nocturnal hemoglobinuria and eculizumab. Haematologica 95:523\u2013526","journal-title":"Haematologica"},{"key":"10_CR46","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1182\/blood.V89.4.1173","volume":"89","author":"JP Maciejewski","year":"1997","unstructured":"Maciejewski JP, Sloand EM, Sato T et al (1997) Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria\/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone. Blood 89:1173\u20131181","journal-title":"Blood"},{"key":"10_CR47","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood.V79.6.1400.1400","volume":"79","author":"JF Mahoney","year":"1992","unstructured":"Mahoney JF, Urakaze M, Hall S et al (1992) Defective glycosylphosphatidylinositol anchor synthesis in paroxysmal nocturnal hemoglobinuria granulocytes. Blood 79:1400\u20131403","journal-title":"Blood"},{"key":"10_CR48","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.it.2007.02.006","volume":"28","author":"MM Markiewski","year":"2007","unstructured":"Markiewski MM, Nilsson B, Ekdahl KN et al (2007) Complement and coagulation: strangers or partners in crime? Trends Immunol 28:184\u2013192","journal-title":"Trends Immunol"},{"key":"10_CR49","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nm0895-839","volume":"1","author":"LA Matis","year":"1995","unstructured":"Matis LA, Rollins SA (1995) Complement-specific antibodies: designing novel anti-inflammatories. Nat Med 1:839\u2013842","journal-title":"Nat Med"},{"key":"10_CR50","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1172\/JCI113043","volume":"80","author":"ME Medof","year":"1987","unstructured":"Medof ME, Gottlieb A, Kinoshita T et al (1987) Relationship between decay accelerating factor deficiency, diminished acetylcholinesterase activity, and defective terminal complement pathway restriction in paroxysmal nocturnal hemoglobinuria erythrocytes. J Clin Invest 80:165\u2013174","journal-title":"J Clin Invest"},{"key":"10_CR51","first-page":"1","volume":"71","author":"S Meri","year":"1990","unstructured":"Meri S, Morgan BP, Davies A et al (1990) Human protectin (CD59), an 18,000\u201320,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers. Immunology 71:1\u20139","journal-title":"Immunology"},{"key":"10_CR52","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-2141.1989.tb00260.x","volume":"73","author":"AH Merry","year":"1989","unstructured":"Merry AH, Rawlinson VI, Uchikawa M et al (1989) Studies on the sensitivity to complement-mediated lysis of erythrocytes (Inab phenotype) with a deficiency of DAF (decay accelerating factor). Br J Haematol 73:248\u2013253","journal-title":"Br J Haematol"},{"key":"10_CR53","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.7680492","volume":"259","author":"T Miyata","year":"1993","unstructured":"Miyata T, Takeda J, Iida Y et al (1993) The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science 259:1318\u20131320","journal-title":"Science"},{"key":"10_CR54","doi-asserted-by":"crossref","first-page":"3836","DOI":"10.4049\/jimmunol.145.11.3836","volume":"145","author":"C Mold","year":"1990","unstructured":"Mold C, Walter EI, Medof ME (1990) The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor. J Immunol 145:3836\u20133841","journal-title":"J Immunol"},{"key":"10_CR55","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/eji.1830221029","volume":"22","author":"N Motoyama","year":"1992","unstructured":"Motoyama N, Okada N, Yamashina M et al (1992) Paroxysmal nocturnal hemoglobinuria due to hereditary nucleotide deletion in the HRF20 (CD59) gene. Eur J Immunol 22:2669\u20132673","journal-title":"Eur J Immunol"},{"key":"10_CR56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2141.2004.04992.x","volume":"126","author":"VM Moyo","year":"2004","unstructured":"Moyo VM, Mukhina GL, Garrett ES et al (2004) Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol 126:133\u2013138","journal-title":"Br J Haematol"},{"key":"10_CR57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev.bi.57.070188.001541","volume":"57","author":"HJ M\u00fcller-Eberhard","year":"1988","unstructured":"M\u00fcller-Eberhard HJ (1988) Molecular organization and function of the complement system. Annu Rev Biochem 57:321\u2013347","journal-title":"Annu Rev Biochem"},{"key":"10_CR58","first-page":"7","volume":"178","author":"A Nicholson-Weller","year":"1992","unstructured":"Nicholson-Weller A (1992) Decay accelerating factor (CD55). Curr Top Microbiol Immunol 178:7\u201330","journal-title":"Curr Top Microbiol Immunol"},{"key":"10_CR59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.4049\/jimmunol.129.1.184","volume":"129","author":"A Nicholson-Weller","year":"1982","unstructured":"Nicholson-Weller A, Burge J, Fearon DT et al (1982) Isolation of a human erythrocyte membrane glycoprotein with decay-accelerating activity for C3 convertases of the complement system. J Immunol 129:184\u2013189","journal-title":"J Immunol"},{"key":"10_CR60","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1073\/pnas.80.16.5066","volume":"80","author":"A Nicholson-Weller","year":"1983","unstructured":"Nicholson-Weller A, March JP, Rosenfeld SI et al (1983) Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor. Proc Natl Acad Sci USA 80:5066\u20135070","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR61","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0925-5710(96)00559-2","volume":"65","author":"H Ninomiya","year":"1997","unstructured":"Ninomiya H, Hasegawa Y, Nagasawa T et al (1997) Excess soluble urokinase-type plasminogen activator receptor in the plasma of patients with paroxysmal nocturnal hemoglobinuria inhibits cell-associated fibrinolytic activity. Int J Hematol 65:285\u2013291","journal-title":"Int J Hematol"},{"key":"10_CR62","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1182\/blood.V89.9.3470","volume":"89","author":"J Nishimura","year":"1997","unstructured":"Nishimura J, Inoue N, Wada H et al (1997) A patient with paroxysmal nocturnal hemoglobinuria bearing four independent PIG-A mutant clones. Blood 89:3470\u20133476","journal-title":"Blood"},{"key":"10_CR63","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1182\/blood.V99.8.2748","volume":"99","author":"J Nishimura","year":"2002","unstructured":"Nishimura J Ji, Hirota T, Kanakura Y et al (2002) Long-term support of hematopoiesis by a single stem cell clone in patients with paroxysmal nocturnal hemoglobinuria. Blood 99:2748\u20132751","journal-title":"Blood"},{"key":"10_CR64","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/01.md.0000126763.68170.46","volume":"83","author":"J Nishimura","year":"2004","unstructured":"Nishimura J, Kanakura Y, Ware RE et al (2004) Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. Medicine (Baltimore) 83:193\u2013207","journal-title":"Medicine (Baltimore)"},{"key":"10_CR65","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood.V36.2.145.145","volume":"36","author":"BS Oni","year":"1970","unstructured":"Oni BS, Osunkoya BO, Luzzatto L (1970) Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood 36:145\u2013152","journal-title":"Blood"},{"key":"10_CR66","unstructured":"Orphanet (2004) Paroxysmal nocturnal hemoglobinuria, 1-12-2004. Ref Type: Internet Communication"},{"key":"10_CR67","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1749-6632.1983.tb18116.x","volume":"421","author":"MK Pangburn","year":"1983","unstructured":"Pangburn MK, M\u00fcller-Eberhard HJ (1983) Initiation of the alternative complement pathway due to spontaneous hydrolysis of the thioester of C3. Ann N Y Acad Sci 421:291\u2013298","journal-title":"Ann N Y Acad Sci"},{"key":"10_CR68","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1084\/jem.154.3.856","volume":"154","author":"MK Pangburn","year":"1981","unstructured":"Pangburn MK, Schreiber RD, M\u00fcller-Eberhard HJ (1981) Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3. J Exp Med 154:856\u2013867","journal-title":"J Exp Med"},{"key":"10_CR69","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1084\/jem.157.6.1971","volume":"157","author":"MK Pangburn","year":"1983","unstructured":"Pangburn MK, Schreiber RD, Trombold JS et al (1983a) Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes. J Exp Med 157:1971\u20131980","journal-title":"J Exp Med"},{"key":"10_CR70","doi-asserted-by":"crossref","first-page":"5430","DOI":"10.1073\/pnas.80.17.5430","volume":"80","author":"MK Pangburn","year":"1983","unstructured":"Pangburn MK, Schreiber RD, M\u00fcller-Eberhard HJ (1983b) Deficiency of an erythrocyte membrane protein with complement regulatory activity in paroxysmal nocturnal hemoglobinuria. Proc Natl Acad Sci USA 80:5430\u20135434","journal-title":"Proc Natl Acad Sci USA"},{"key":"10_CR71","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.4049\/jimmunol.131.4.1930","volume":"131","author":"MK Pangburn","year":"1983","unstructured":"Pangburn MK, Schreiber RD, M\u00fcller-Eberhard HJ (1983c) C3b deposition during activation of the alternative complement pathway and the effect of deposition on the activating surface. J Immunol 131:1930\u20131935","journal-title":"J Immunol"},{"key":"10_CR72","first-page":"1203","volume-title":"Wintrobe\u2019s clinical hematology","author":"CJ Parker","year":"2003","unstructured":"Parker CJ, Ware RE (2003) Paroxysmal nocturnal hemoglobinuria. In: Greer J et al (eds) Wintrobe\u2019s clinical hematology, 11th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1203\u20131221","edition":"11"},{"key":"10_CR73","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1172\/JCI110457","volume":"69","author":"CJ Parker","year":"1982","unstructured":"Parker CJ, Baker PJ, Rosse WF (1982) Increased enzymatic activity of the alternative pathway convertase when bound to the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest 69:337\u2013346","journal-title":"J Clin Invest"},{"key":"10_CR74","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker C, Omine M, Richards S, International PNH Interest Group et al (2005) Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106:3699\u20133709","journal-title":"Blood"},{"key":"10_CR75","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1182\/blood-2004-11-4315","volume":"106","author":"A Poggi","year":"2005","unstructured":"Poggi A, Negrini S, Zocchi MR et al (2005) Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors. Blood 106: 2399\u20132408","journal-title":"Blood"},{"key":"10_CR76","first-page":"273","volume":"632","author":"D Ricklin","year":"2008","unstructured":"Ricklin D, Lambris JD (2008) Compstatin: a complement inhibitor on its way to clinical application. Adv Exp Med Biol 632:273\u2013292","journal-title":"Adv Exp Med Biol"},{"key":"10_CR77","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0140-6736(04)16724-X","volume":"364","author":"AM Risitano","year":"2004","unstructured":"Risitano AM, Maciejewski JP, Green S et al (2004) In vivo dominant immune responses in aplastic anemia patients: molecular tracking of putatively pathogenic T cells by TCR\u03b2-CDR3 sequencing. Lancet 364:353\u2013363","journal-title":"Lancet"},{"key":"10_CR78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2008-04-151613","volume":"112","author":"AM Risitano","year":"2008","unstructured":"Risitano AM, Marando L, Seneca E et al (2008) Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab. Blood 112:449\u2013451","journal-title":"Blood"},{"key":"10_CR79","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1182\/blood-2008-11-189944","volume":"113","author":"AM Risitano","year":"2009","unstructured":"Risitano AM, Notaro R, Marando L et al (2009a) Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood 113:4094\u20134100","journal-title":"Blood"},{"key":"10_CR80","doi-asserted-by":"crossref","first-page":"158a","DOI":"10.1182\/blood.V114.22.158.158","volume":"114","author":"AM Risitano","year":"2009","unstructured":"Risitano AM, Holers VM, Rotoli B (2009b) TT30, a novel regulator of the complement alternative pathway (CAP), inhibits hemolysis of paroxysmal nocturnal hemoglobinuria (PNH) erythrocytes and prevents upstream C3 binding on their surface in an in vitro model. Blood 114:158a","journal-title":"Blood"},{"key":"10_CR81","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1056\/NEJMc1010351","volume":"363","author":"AM Risitano","year":"2010","unstructured":"Risitano AM, Notaro R, Luzzatto L et al (2010) Paroxysmal nocturnal hemoglobinuria: hemolysis before and after eculizumab. N Engl J Med 363:2270\u20132272","journal-title":"N Engl J Med"},{"key":"10_CR111","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1056\/NEJMc1010351","volume":"363","author":"AM Risitano","year":"2010","unstructured":"Risitano AM, Notaro R, Pascariello C et al (2012) The complement receptor 2\/factor H fusion protein TT30 protects paroxysmal nocturnal hemoglobinuria erythrocytes from complement mediated hemolysis and C3 fragment. May 2012, [Epub ahead of print]","journal-title":"N Engl J Med"},{"key":"10_CR82","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1182\/blood.V37.5.556.556","volume":"37","author":"WF Rosse","year":"1971","unstructured":"Rosse WF (1971) The life-span of complement-sensitive and -insensitive red cells in paroxysmal nocturnal hemoglobinuria. Blood 37:556\u2013562","journal-title":"Blood"},{"key":"10_CR83","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1172\/JCI105388","volume":"45","author":"WF Rosse","year":"1966","unstructured":"Rosse WF, Dacie JV (1966) Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody. J Clin Invest 45:736\u2013748","journal-title":"J Clin Invest"},{"key":"10_CR84","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1001\/jama.293.13.1653","volume":"293","author":"RP Rother","year":"2005","unstructured":"Rother RP, Bell L, Hillmen P et al (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293:1653\u20131662","journal-title":"JAMA"},{"key":"10_CR85","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/nbt1344","volume":"25","author":"RP Rother","year":"2007","unstructured":"Rother RP, Rollins SA, Mojcik CF et al (2007) Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol 25:1256\u20131264","journal-title":"Nat Biotechnol"},{"key":"10_CR86","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0950-3536(89)80010-1","volume":"2","author":"B Rotoli","year":"1989","unstructured":"Rotoli B, Luzzatto L (1989) Paroxysmal nocturnal haemoglobinuria. Baillieres Clin Haematol 2:113\u2013138","journal-title":"Baillieres Clin Haematol"},{"key":"10_CR87","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1182\/blood.V60.1.157.157","volume":"60","author":"B Rotoli","year":"1982","unstructured":"Rotoli B, Robledo R, Luzzatto L (1982) Decreased number of circulating BFU-Es in paroxysmal nocturnal hemoglobinuria. Blood 60:157\u2013159","journal-title":"Blood"},{"key":"10_CR88","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1161\/01.CIR.0000126837.88743.DD","volume":"109","author":"A Schafer","year":"2004","unstructured":"Schafer A, Wiesmann F, Neubauer S et al (2004) Rapid regulation of platelet activation in vivo by nitric oxide. Circulation 109:1819\u20131822","journal-title":"Circulation"},{"key":"10_CR89","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.3324\/haematol.2009.017889","volume":"95","author":"P Scheinberg","year":"2010","unstructured":"Scheinberg P, Marte M, Nunez O et al (2010) Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine. Haematologica 95:1075\u20131080","journal-title":"Haematologica"},{"key":"10_CR90","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/333565a0","volume":"333","author":"P Selvaraj","year":"1988","unstructured":"Selvaraj P, Rosse WF, Silber R et al (1988) The major Fc receptor in blood has a phosphatidylinositol anchor and is deficient in paroxysmal nocturnal haemoglobinuria. Nature 333:565\u2013567","journal-title":"Nature"},{"key":"10_CR91","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.136.5.1777","volume":"136","author":"ML Shin","year":"1986","unstructured":"Shin ML, H\u00e4nsch G, Hu VW et al (1986) Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9. J Immunol 136:1777\u20131782","journal-title":"J Immunol"},{"issue":"s2","key":"10_CR92","first-page":"196(a)","volume":"95","author":"M Sica","year":"2010","unstructured":"Sica M, Pascariello C, Rondelli T et al (2010) In vitro complement protein 5 (C5) blockade recapitulates the complement protein 3 (C3) binding to GPI-negative erythrocytes observed in paroxysmal nocturnal hemoglobinuria (PNH) patients on eculizumab. Haematologica 95(s2):196(a)","journal-title":"Haematologica"},{"key":"10_CR93","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/j.1365-2141.2004.04974.x","volume":"125","author":"J Simak","year":"2004","unstructured":"Simak J, Holada K, Risitano AM et al (2004) Elevated counts of circulating endothelial membrane microparticles in paroxysmal nocturnal hemoglobinuria indicate inflammatory status and ongoing stimulation of vascular endothelium. Br J Hematol 125:804\u2013813","journal-title":"Br J Hematol"},{"key":"10_CR94","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/j.exphem.2008.06.016","volume":"36","author":"EM Sloand","year":"2008","unstructured":"Sloand EM, Pfannes L, Scheinberg P et al (2008) Increased soluble urokinase plasminogen activator receptor (suPAR) is associated with thrombosis and inhibition of plasmin generation in paroxysmal nocturnal hemoglobinuria (PNH) patients. Exp Hematol 36:1616\u20131624","journal-title":"Exp Hematol"},{"key":"10_CR95","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","volume":"348","author":"G Socie","year":"1996","unstructured":"Socie G, Mary JY, de Gramont A et al (1996) Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. Lancet 348:573\u2013577","journal-title":"Lancet"},{"key":"10_CR96","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1182\/blood-2005-06-2485","volume":"107","author":"C Sugimori","year":"2006","unstructured":"Sugimori C, Chuhjo T, Feng X et al (2006) Minor population of CD55-CD59-blood cells predicts response to immunosuppressive therapy and prognosis in patients with aplastic anemia. Blood 107:1308\u20131314","journal-title":"Blood"},{"key":"10_CR97","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1084\/jem.177.2.517","volume":"177","author":"M Takahashi","year":"1993","unstructured":"Takahashi M, Takeda J, Hirose S et al (1993) Deficient biosynthesis of N-acetylglucosaminyl-phosphatidylinositol, the first intermediate of glycosyl phosphatidylinositol anchor biosynthesis, in cell lines established from patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 177:517\u2013521","journal-title":"J Exp Med"},{"key":"10_CR98","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","volume":"73","author":"J Takeda","year":"1993","unstructured":"Takeda J, Miyata T, Kawagoe K et al (1993) Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703\u2013711","journal-title":"Cell"},{"key":"10_CR99","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1182\/blood.V94.9.2945","volume":"94","author":"G Tremml","year":"1999","unstructured":"Tremml G, Dominguez C, Rosti V et al (1999) Increased sensitivity to complement and a decreased red blood cell life span in mice mosaic for a nonfunctional Piga gene. Blood 94:2945\u20132954","journal-title":"Blood"},{"key":"10_CR100","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3324\/haematol.2009.008938","volume":"94","author":"EJ Beers van","year":"2009","unstructured":"van Beers EJ, Schaap MC, Berckmans RJ, CURAMA Study Group et al (2009) Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease. Haematologica 94:1513\u20131519","journal-title":"Haematologica"},{"key":"10_CR101","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1182\/blood.V76.9.1853.1853","volume":"76","author":"CE Schoot van der","year":"1990","unstructured":"van der Schoot CE, Huizinga TW, van\u2019t Veer-Korthof ET et al (1990) Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood 76:1853\u20131859","journal-title":"Blood"},{"key":"10_CR102","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1084\/jem.144.5.1147","volume":"144","author":"K Whaley","year":"1976","unstructured":"Whaley K, Ruddy S (1976) Modulation of the alternative complement pathway by \u03b21H globulin. J Exp Med 144:1147\u20131163","journal-title":"J Exp Med"},{"key":"10_CR103","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1182\/blood.V82.4.1192.1192","volume":"82","author":"T Wiedmer","year":"1993","unstructured":"Wiedmer T, Hall SE, Ortel TL et al (1993) Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. Blood 82:1192\u20131196","journal-title":"Blood"},{"key":"10_CR104","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1182\/blood.V78.3.820.820","volume":"78","author":"LA Wilcox","year":"1991","unstructured":"Wilcox LA, Ezzell JL, Bernshaw NJ et al (1991) Molecular basis of the enhanced susceptibility of the erythrocytes of paroxysmal nocturnal hemoglobinuria to hemolysis in acidified serum. Blood 78:820\u2013829","journal-title":"Blood"},{"key":"10_CR105","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1056\/NEJM199010253231707","volume":"323","author":"M Yamashina","year":"1990","unstructured":"Yamashina M, Ueda E, Kinoshita T et al (1990) Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med 323:1184\u20131189","journal-title":"N Engl J Med"},{"key":"10_CR106","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1172\/JCI11002","volume":"106","author":"NS Young","year":"2000","unstructured":"Young NS, Maciejewski JP (2000) Genetic and environmental effects in paroxysmal nocturnal hemoglobinuria: this little PIG-A goes \u201cWhy? Why? Why?\u201d. J Clin Invest 106:637\u2013641","journal-title":"J Clin Invest"},{"key":"10_CR107","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1182\/blood-2006-03-010777","volume":"108","author":"NS Young","year":"2006","unstructured":"Young NS, Calado RT, Scheinberg P (2006) Current concepts in the pathophysiology and treatment of aplastic anemia. Blood 108:2509\u20132519","journal-title":"Blood"}],"container-title":["Advances in Experimental Medicine and Biology","Complement Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-4118-2_10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T10:43:47Z","timestamp":1714387427000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-4118-2_10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,10]]},"ISBN":["9781461441175","9781461441182"],"references-count":108,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-4118-2_10","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,10]]},"assertion":[{"value":"10 August 2012","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}